Significance of the Expression of Rho-GDP Dissociation Inhibitor β,γ in Lung Squamous Cell Carcinoma and Adenocarcinoma

被引:0
|
作者
孙曼妮 [1 ]
李晓倩 [1 ]
周静怡 [2 ]
刘冬明 [1 ]
韩昱晨 [3 ]
机构
[1] Department of Clinic Medicine,Basic Medicine College,China Medical University
[2] Department of Medical Biology,Basic Medicine College,China Medical University
[3] Department of Pathology,Basic Medicine College,China Medical University
关键词
Lung squamous cell carcinoma and adenocarcinoma; Rho-GDIβ; Rho-GDIγ; RhoC;
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100214 ;
摘要
Objective:To study the expression of Rho-GDP dissociation inhibitor β,γ(Rho-GDIβ,Rho-GDIγ)in lung squamous cell carcinoma and adenocarcinoma and its relationship with the expression of RhoC(Ras homologus oncogenes C)and clinicopathologic parameters.Methods:Western blot assay was employed for Rho-GDIβ,Rho-GDIγ and RhoC in lung squamous cell carcinoma and adenocarcinoma and non-neoplastic lung tissues of 37 cases with fresh specimens.Results:The study showed that Rho-GDIβ,Rho-GDIγ and RhoC were expressed in lung cancer and non-neoplastic lung tissues,the level in lung cancer tissue was much higher than that in non-neoplastic tissues(P<0.001).In lung cancer,the expression of Rho-GDIβ was much higher in patients with lymph node metastasis(P=0.021),and the expression of Rho-GDIγ was much higher in poorly differentiated tumor than in well-differentiated and moderately differentiated tumor,but both of them were not correlated with other clinicopathologic parameters.The expressions of Rho-GDIβ and Rho-GDIγ were not correlated with the expression of RhoC.Conclusion:In lung cancer,Rho-GDIβ and Rho-GDIγ may play a role in the tumorigenesis,Rho-GDIβ may promote metastasis,and Rho-GDIγ may have some relationship with differentiation.
引用
收藏
页码:287 / 290
页数:4
相关论文
共 50 条
  • [41] Differences in the early stage gene expression profiles of lung adenocarcinoma and lung squamous cell carcinoma
    Venugopal, Nitin
    Yeh, Justin
    Kodeboyina, Sai Karthik
    Lee, Tae Jin
    Sharma, Shruti
    Patel, Nikhil
    Sharma, Ashok
    [J]. ONCOLOGY LETTERS, 2019, 18 (06) : 6572 - 6582
  • [42] Expression of Rho GDP Dissociation Inhibitor Correlates Positively With Lymph Node Metastasis in Colorectal Cancer
    Nagano, K.
    Okamura, T.
    Yamashita, T.
    Kanasaki, S.
    Maeda, Y.
    Inoue, M.
    Abe, Y.
    Kamada, H.
    Tsutsumi, Y.
    Tsunoda, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S64 - S64
  • [43] LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma
    Liu, Bing
    Chen, Yifei
    Yang, Jiong
    [J]. ONCOTARGET, 2017, 8 (15) : 24275 - 24291
  • [44] RhoGDI gamma: A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas
    Adra, CN
    Manor, D
    Ko, JL
    Zhu, SC
    Horiuchi, T
    VanAelst, L
    Cerione, RA
    Lim, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4279 - 4284
  • [45] Expression and Significance of RKIP and E-cadherin in Lung Squamous Cell Carcinoma
    Zhu, Chunrong
    Wang, Qingcai
    Xie, Jing
    Shi, Jinfang
    Zhou, Xiumin
    Li, Dapeng
    Xiong, Feng
    Zhang, Lu
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (01) : 19 - 26
  • [46] Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance
    Guo, Feng
    Hiroshima, Kenzo
    Wu, Di
    Satoh, Mamoru
    Abulazi, Mayinuer
    Yoshino, Ichiro
    Tomonaga, Takeshi
    Nomura, Fumio
    Nakatani, Yukio
    [J]. HUMAN PATHOLOGY, 2012, 43 (08) : 1282 - 1288
  • [47] Significance of CD109 expression in lung squamous cell carcinoma cells
    Nanaura, Natsumi
    Sakurai, Yasutaka
    Murakumo, Yoshiki
    [J]. CANCER SCIENCE, 2018, 109 : 1105 - 1105
  • [48] Profiling mesothelin protein expression by immunohistochemistry and gene expression in adenocarcinoma and squamous cell carcinoma of lung
    Wong, Jackson
    Gaffney, Dana
    Sharp, Michael
    Hertzog, Brenda
    Karkera, Jayaprakash
    Platero, Suso
    Alvarez, John
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [49] ADENOCARCINOMA OF RECTUM - SQUAMOUS-CELL CARCINOMA OF LUNG
    SCHIER, WW
    WYMAN, SM
    CASTLEMAN, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1947, 237 (17): : 645 - 647
  • [50] Synergism of KRAS G12C Inhibitor and mTOR Inhibitor in Lung Adenocarcinoma and Squamous Cell Carcinoma
    Ito, M.
    Miyata, Y.
    Hirano, S.
    Morihara, N.
    Irisuna, F.
    Takemoto, M.
    Tsutani, Y.
    Okada, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S429 - S429